Verition Fund Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,100
Closed -$1.54M 2624
2025
Q4
$1.54M Sell
100,100
-64,358
-39% -$709K 0.01% 1827
2025
Q3
$1.63M Buy
164,458
+146,988
+841% +$1.53M 0.01% 2144
2025
Q2
$173K Sell
17,470
-35,623
-67% -$375K ﹤0.01% 3398
2025
Q1
$689K Buy
53,093
+21,055
+66% +$279K ﹤0.01% 2373
2024
Q4
$409K Buy
32,038
+14,155
+79% +$171K ﹤0.01% 2593
2024
Q3
$199K Buy
17,883
+2,999
+20% +$33.1K ﹤0.01% 2889
2024
Q2
$167K Buy
+14,884
New +$173K ﹤0.01% 2648
2023
Q3
Sell
-20,000
Closed -$258K 2427
2023
Q2
$258K Buy
+20,000
New +$228K ﹤0.01% 1673
2022
Q2
Sell
-249,017
Closed -$2.7M 2529
2022
Q1
$2.7M Buy
+249,017
New +$3.02M 0.03% 750
2014
Q1
Sell
-1,995
Closed -$39K 523
2013
Q4
$39K Buy
+1,995
New +$29.2K 0.01% 484

Other funds holding DVAX

Verition Fund Management's DVAX Position: Q1 2026 in Review

Verition Fund Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 100,100 shares — an estimated $1.54M sold.

Verition Fund Management first reported a position in DVAX in Q4 2013 and held it in 10 quarters. The position peaked at $2.7M in Q1 2022. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Verition Fund Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 100,100 Dynavax Technologies shares in Q1 2026, an estimated $1.54M.
  • Verition Fund Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 10 quarters.
  • Verition Fund Management's Dynavax Technologies position peaked at $2.7M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.